Insight Molecular Diagnostics Return on Tangible Equity 2014-2025 | IMDX

Current and historical return on tangible equity values for Insight Molecular Diagnostics (IMDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Insight Molecular Diagnostics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.06B $0.00B 210.71%
2024-12-31 $-0.06B $-0.03B 159.48%
2024-09-30 $-0.04B $-0.05B 108.64%
2024-06-30 $-0.04B $-0.03B 113.43%
2024-03-31 $-0.04B $-0.05B 145.13%
2023-12-31 $-0.03B $-0.04B 133.33%
2023-09-30 $-0.06B $-0.02B 292.31%
2023-06-30 $-0.06B $-0.01B 269.66%
2023-03-31 $-0.06B $-0.02B 237.62%
2022-12-31 $-0.07B $-0.03B 217.91%
2022-09-30 $-0.06B $-0.03B 209.84%
2022-06-30 $-0.07B $-0.03B 261.54%
2022-03-31 $-0.07B $-0.05B 297.87%
2021-12-31 $-0.06B $-0.02B -3657.14%
2021-09-30 $-0.03B $-0.01B -438.71%
2021-06-30 $-0.03B $-0.02B -203.77%
2021-03-31 $-0.03B $0.05B -125.30%
2020-12-31 $-0.03B $0.01B -260.87%
2020-09-30 $-0.03B $0.01B -188.24%
2020-06-30 $-0.03B $0.02B -137.93%
2020-03-31 $-0.03B $0.01B -98.11%
2019-12-31 $-0.02B $0.03B -66.67%
2019-09-30 $-0.02B $0.03B -73.08%
2019-06-30 $-0.02B $0.03B -81.93%
2019-03-31 $-0.02B $0.04B -121.43%
2018-12-31 $-0.02B $0.00B -261.54%
2018-09-30 $-0.02B $0.01B -237.04%
2018-06-30 $-0.02B $0.01B -307.69%
2018-03-31 $-0.02B $0.01B -316.67%
2017-12-31 $-0.02B $0.00B -333.33%
2017-09-30 $-0.02B $0.01B -262.07%
2017-06-30 $-0.02B $0.01B -176.47%
2017-03-31 $-0.01B $0.01B -175.00%
2016-12-31 $-0.01B $0.01B -160.00%
2016-09-30 $-0.01B $0.01B -173.33%
2016-06-30 $-0.01B $0.00B -266.67%
2016-03-31 $-0.01B $0.01B -266.67%
2015-12-31 $-0.01B $0.01B -355.56%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.069B $0.002B
Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $44.935B 57.17
Tempus AI (TEM) United States $12.393B 0.00
Doximity (DOCS) United States $11.901B 52.95
Hims & Hers Health (HIMS) United States $10.549B 87.28
IRhythm Technologies (IRTC) United States $5.208B 0.00
Hinge Health (HNGE) United States $4.462B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.501B 36.77
Phreesia (PHR) United States $1.667B 0.00
Enovis (ENOV) United States $1.647B 8.71
10x Genomics (TXG) United States $1.630B 0.00
Omnicell (OMCL) United States $1.446B 27.85
Schrodinger (SDGR) United States $1.427B 0.00
Azenta (AZTA) United States $1.402B 61.18
Clover Health Investments (CLOV) United States $1.317B 0.00
Claritev (CTEV) United States $1.117B 0.00
Evolent Health (EVH) United States $1.035B 0.00
Fulgent Genetics (FLGT) United States $0.665B 0.00
Zepp Health (ZEPP) Netherlands $0.509B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Talkspace (TALK) United States $0.424B 126.50
Carlsmed (CARL) $0.370B 0.00
Butterfly Network (BFLY) United States $0.355B 0.00
TruBridge (TBRG) United States $0.287B 50.40
Nyxoah SA (NYXH) Belgium $0.232B 0.00
Outset Medical (OM) United States $0.229B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.222B 0.00
Health Catalyst (HCAT) United States $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.134B 0.00
American Well (AMWL) United States $0.117B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.057B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00